Sartorius Stedim consensus picture on Tuesday, shares tracked on Euronext Paris

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-30, 09:32.

Sartorius Stedim (FR0013154002) starts this Tuesday with attention on its analyst consensus and valuation metrics. The shares are traded on Euronext Paris, giving the stock a visible anchor in the European life-science equipment segment.

Analyst views on Sartorius Stedim

The consensus setting for Sartorius Stedim typically reflects its role as a supplier of bioprocessing equipment and single-use systems to the biopharmaceutical industry. Research houses that follow European mid caps in healthcare often include the stock in their coverage lists alongside peers such as Merck KGaA and Lonza.

Analysts usually focus on recurring revenue share, margin resilience and order intake from biopharma customers when assessing Sartorius Stedim. Rating distributions tend to balance growth expectations from biologics and cell-therapy manufacturing against cyclicality in capital spending.

How consensus informs investors

For retail investors, consensus estimates on Sartorius Stedim’s revenue, EBITDA margin and earnings per share provide a structured view of expectations for the next fiscal periods. Typical models look at the installed base of equipment and consumables, plus the trajectory of biopharmaceutical capex.

Target prices from covering analysts frequently incorporate scenarios for expansion of single-use technologies, potential pricing power in filtration and chromatography solutions, and the company’s exposure to contract development and manufacturing organizations as end customers.

The products behind the stock

Sartorius Stedim Biotech focuses on equipment and consumables for biopharmaceutical manufacturing, including bioreactors, filtration systems and single-use bags. These products support upstream and downstream processing steps in the production of monoclonal antibodies and advanced therapies.

Where the Sartorius Stedim shares trade

The Sartorius Stedim shares (FR0013154002) trade on Euronext Paris, with prices quoted in euros and intraday liquidity shaped by institutional and retail flows on the French exchange.

This text is for informational purposes only and does not constitute investment advice, a recommendation to buy or sell securities, or a solicitation of any transaction. All data are based on publicly available information and may change without notice. Investors should conduct their own research and, if necessary, seek professional advice before making investment decisions.